Factors associated with low adherence to medicine treatment for chronic diseases in brazil

Show simple item record

dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Bertoldi, Andres Damaso
dc.contributor.author Mengue, Sotero Serrate
dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Oliveira, Maria Auxiliadora
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Dal Pizzol, Tatiane da Silva
dc.date.accessioned 2019-01-21T10:29:36Z
dc.date.available 2019-01-21T10:29:36Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006150
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 10s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49283
dc.description.abstract OBJECTIVE: To analyze factors associated with low adherence to drug treatment for chronic diseases in Brazil. METHODS: Analysis of data from Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - Brazilian Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based cross-sectional household survey, based on a probabilistic sample of the Brazilian population. We analyzed the association between low adherence to drug treatment measured by the Brief Medication Questionnaire and demographic, socioeconomic, health, care and prescription factors. We used Poisson regression model to estimate crude and adjusted prevalence ratios, their respective 95% confidence interval (95% CI) and p-value (Wald test). RESULTS: The prevalence of low adherence to drug treatment for chronic diseases was 30.8% (95% CI 28.8-33.0). The highest prevalence of low adherence was associated with individuals: young adults en
dc.description.abstract no education en
dc.description.abstract resident in the Northeast and Midwest Regions of Brazil en
dc.description.abstract paying part of the treatment en
dc.description.abstract poor self-perceived health en
dc.description.abstract three or more diseases en
dc.description.abstract reported limitations caused by a chronic disease en
dc.description.abstract using five drugs or more. CONCLUSIONS: Low adherence to drug treatment for chronic diseases in Brazil is relevant, and regional and demographic differences and those related to patients' health care and therapy regime require coordinated action between health professionals, researchers, managers and policy makers. en
dc.description.sponsorship Department of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.description.sponsorship Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.format.extent 10s
dc.language.iso eng
dc.publisher Iop Publishing Ltd
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Medication Adherence en
dc.subject Primary-Care en
dc.subject Hypertension en
dc.subject Nonadherence en
dc.subject Metaanalysis en
dc.subject Frequency en
dc.title Factors associated with low adherence to medicine treatment for chronic diseases in brazil en
dc.title Fatores associados à baixa adesão ao tratamento farmacológico de doenças crônicas no Brasil pt
dc.type Artigo
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliation Programa de Pós-Graduação em Epidemiologia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE/MS: 25000.111834/2011-31
dc.identifier.file S0034-89102016000300307.pdf
dc.identifier.scielo S0034-89102016000300307
dc.identifier.doi 10.1590/S1518-8787.2016050006150
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400007



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account